News
The S&P 500 rose 0.4% on Friday (July 25), capping a winning week fueled by strong earnings and positive trade developments.
Despite this cautious outlook, Qualcomm’s strong position in 5G technology and its diversified product portfolio continue to ...
Diversified Healthcare Trust shifts focus to asset management, showing promise with SHOP stabilization and debt reduction.
JPMorgan Chase is an advertising partner of Motley Fool Money. Adam Spatacco has positions in Alphabet and Nvidia. The Motley ...
Friday marked another winning day for the S&P 500 and Nasdaq, as both indexes posted fresh all-time intraday and closing ...
Micron Technology, Inc. (NASDAQ:MU) is one of the must-buy semiconductor stocks to invest in. Arete Research has lifted its ...
21h
Zacks Investment Research on MSNWhy Itron (ITRI) Outpaced the Stock Market TodayIn the latest trading session, Itron (ITRI) closed at $135.97, marking a +1.48% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.4%. Elsewhere, the Dow ...
8h
MarketBeat on MSNMarketBeat Week in Review – 07/21 - 07/25Stocks were up this week as the summer rally continues. There was mixed news from the tech sector this week, but on the whole, earnings have been better-than-expected. That trend will likely continue ...
21h
Zacks Investment Research on MSNHumacyte, Inc. (HUMA) Stock Dips While Market Gains: Key FactsIn the latest trading session, Humacyte, Inc. (HUMA) closed at $2.53, marking a -5.24% move from the previous day. This move lagged the S&P 500's daily gain of 0.4%. On the other hand, the Dow ...
21h
Zacks Investment Research on MSNGriffon (GFF) Beats Stock Market Upswing: What Investors Need to KnowGriffon (GFF) ended the recent trading session at $82.65, demonstrating a +1.37% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.4 ...
21h
Zacks Investment Research on MSNEnbridge (ENB) Stock Declines While Market Improves: Some Information for InvestorsEnbridge (ENB) closed the most recent trading day at $44.97, moving -1.08% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.4%. Elsewhere, the Dow ...
21h
Zacks Investment Research on MSNSynopsys (SNPS) Stock Sinks As Market Gains: What You Should KnowSynopsys (SNPS) closed the most recent trading day at $601.55, moving -1.33% from the previous trading session. This change lagged the S&P 500's daily gain of 0.4%. Meanwhile, the Dow experienced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results